pI: 8.4372 |
Length (AA): 729 |
MW (Da): 80620 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
2 | 469 | 4rer (A) | 12 | 544 | 33.00 | 0 | 1 | 0.812675 | 0.78 |
2 | 372 | 4rer (A) | 12 | 366 | 43.00 | 0 | 1 | 0.917716 | 0.3 |
5 | 273 | 3mn3 (A) | 52 | 318 | 52.00 | 0 | 1 | 0.965799 | -0.78 |
8 | 261 | 2bdw (A) | 13 | 271 | 42.00 | 0 | 1 | 0.926422 | -1.07 |
621 | 704 | 3t4n (A) | 506 | 626 | 24.00 | 0 | 0.61 | 0.208926 | -0.21 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
NA% percentile | Procyclic. | Siegel TN |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_126655)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G39440 | SNF1-related protein kinase 1.3 |
Arabidopsis thaliana | AT3G01090 | SNF1-related protein kinase catalytic subunit alpha KIN10 |
Arabidopsis thaliana | AT3G29160 | SNF1-related protein kinase catalytic subunit alpha KIN11 |
Babesia bovis | BBOV_III009120 | protein kinase domain containing protein |
Brugia malayi | Bm1_37010 | putative serine/threonine kinase SADA gamma |
Brugia malayi | Bm1_37015 | hypothetical protein |
Brugia malayi | Bm1_50100 | EST embl|AI107989|AI107989 comes from the 3' UTR, putative |
Candida albicans | CaO19.9491 | protein serine/threonine kinase |
Candida albicans | CaO19.4308 | similar to S. cerevisiae HSL1 (YKL101W) serine/threonine-protein kinase involved in cell cycle control |
Candida albicans | CaO19.8280 | bud neck kinase |
Candida albicans | CaO19.11784 | similar to S. cerevisiae HSL1 (YKL101W) serine/threonine-protein kinase involved in cell cycle control |
Candida albicans | CaO19.1936 | protein serine/threonine kinase |
Candida albicans | CaO19.663 | bud neck kinase |
Caenorhabditis elegans | CELE_F15A2.6 | Protein SAD-1, isoform A |
Caenorhabditis elegans | CELE_T01C8.1 | Protein AAK-2, isoform C |
Cryptosporidium parvum | cgd6_650 | OSK4, putative |
Dictyostelium discoideum | DDB_G0277905 | AMP-activated protein kinase alpha subunit |
Dictyostelium discoideum | DDB_G0280133 | CAMKL family protein kinase |
Dictyostelium discoideum | DDB_G0277165 | BRSK subfamily protein kinase |
Drosophila melanogaster | Dmel_CG3051 | AMP-activated protein kinase alpha subunit |
Drosophila melanogaster | Dmel_CG6114 | sugar-free frosting |
Echinococcus granulosus | EgrG_000708800 | 5' AMP activated protein kinase catalytic |
Echinococcus granulosus | EgrG_000915400 | serine:threonine kinase SAD 1 |
Entamoeba histolytica | EHI_110010 | serine/threonine protein kinase, putative |
Echinococcus multilocularis | EmuJ_000708800 | 5' AMP activated protein kinase catalytic |
Echinococcus multilocularis | EmuJ_000915400 | serine:threonine kinase SAD 1 |
Giardia lamblia | GL50803_14364 | Kinase, CAMK CAMKL |
Giardia lamblia | GL50803_16034 | Kinase, CAMK CAMKL |
Homo sapiens | ENSG00000160469 | BR serine/threonine kinase 1 |
Homo sapiens | ENSG00000162409 | protein kinase, AMP-activated, alpha 2 catalytic subunit |
Homo sapiens | ENSG00000174672 | BR serine/threonine kinase 2 |
Homo sapiens | ENSG00000132356 | protein kinase, AMP-activated, alpha 1 catalytic subunit |
Leishmania braziliensis | LbrM.29.1990 | serine/threonine protein kinase, putative,protein kinase, putative |
Leishmania braziliensis | LbrM.35.1020 | protein kinase, putative,SNF1-related protein kinases, putative |
Leishmania donovani | LdBPK_360960.1 | SNF1-related protein kinases, putative |
Leishmania donovani | LdBPK_292140.1 | 5'-AMP-activated protein kinase catalytic subunit alpha, putative |
Leishmania infantum | LinJ.36.0960 | protein kinase, putative,SNF1-related protein kinases, putative |
Leishmania infantum | LinJ.29.2140 | serine/threonine protein kinase, putative,protein kinase, putative |
Leishmania major | LmjF.36.0900 | protein kinase, putative,SNF1-related protein kinases, putative |
Leishmania major | LmjF.29.2020 | serine/threonine protein kinase, putative,protein kinase, putative |
Leishmania mexicana | LmxM.08_29.2020 | serine/threonine protein kinase, putative,protein kinase, putative |
Leishmania mexicana | LmxM.36.0900 | protein kinase, putative |
Loa Loa (eye worm) | LOAG_01209 | hypothetical protein |
Loa Loa (eye worm) | LOAG_01208 | hypothetical protein |
Loa Loa (eye worm) | LOAG_05061 | CAMK/CAMKL/AMPK protein kinase |
Loa Loa (eye worm) | LOAG_01207 | CAMK/CAMKL/BRSK protein kinase |
Loa Loa (eye worm) | LOAG_01206 | hypothetical protein |
Mus musculus | ENSMUSG00000035390 | BR serine/threonine kinase 1 |
Mus musculus | ENSMUSG00000053046 | BR serine/threonine kinase 2 |
Mus musculus | ENSMUSG00000028518 | protein kinase, AMP-activated, alpha 2 catalytic subunit |
Mus musculus | ENSMUSG00000050697 | protein kinase, AMP-activated, alpha 1 catalytic subunit |
Neospora caninum | NCLIV_033490 | hypothetical protein |
Oryza sativa | 4332495 | Os03g0289100 |
Oryza sativa | 4339410 | Os05g0530500 |
Oryza sativa | 4345873 | Os08g0484600 |
Plasmodium falciparum | PF3D7_1454300 | serine/threonine protein kinase KIN |
Plasmodium knowlesi | PKNH_1227800 | serine/threonine protein kinase KIN, putative |
Plasmodium vivax | PVX_117765 | serine/threonine protein kinase KIN, putative |
Saccharomyces cerevisiae | YDR507C | Gin4p |
Saccharomyces cerevisiae | YCL024W | Kcc4p |
Saccharomyces cerevisiae | YKL101W | Hsl1p |
Saccharomyces cerevisiae | YDR477W | AMP-activated serine/threonine-protein kinase catalytic subunit SNF1 |
Schistosoma japonicum | Sjp_0202490 | ko:K07198 5'-AMP-activated protein kinase, catalytic alpha subunit, putative |
Schistosoma japonicum | Sjp_0308150 | HD domain-containing protein 2 homolog, putative |
Schistosoma japonicum | Sjp_0007470 | ko:K08796 BR serine/threonine kinase, putative |
Schistosoma japonicum | Sjp_0007320 | MAP/microtubule affinity-regulating kinase 4, putative |
Schistosoma mansoni | Smp_134910.1 | serine/threonine protein kinase |
Schistosoma mansoni | Smp_169900.1 | serine/threonine protein kinase |
Schistosoma mansoni | Smp_169900.2 | serine/threonine protein kinase |
Schistosoma mansoni | Smp_142990 | serine/threonine protein kinase |
Schistosoma mansoni | Smp_134910.2 | serine/threonine protein kinase |
Schmidtea mediterranea | mk4.018157.00 | |
Schmidtea mediterranea | mk4.016978.00 | |
Schmidtea mediterranea | mk4.025704.00 | |
Schmidtea mediterranea | mk4.030606.00 | AMP-activated protein kinase alpha subunit |
Schmidtea mediterranea | mk4.001868.03 | |
Schmidtea mediterranea | mk4.005918.01 | AMP-activated protein kinase alpha subunit |
Schmidtea mediterranea | mk4.001025.08 | Serine/threonine-protein kinase BRSK2 |
Trypanosoma brucei gambiense | Tbg972.10.6470 | protein kinase, putative,SNF1-related protein kinases, putative |
Trypanosoma brucei gambiense | Tbg972.3.5030 | serine/threonine protein kinase, putative,protein kinase, putative |
Trypanosoma brucei | Tb927.10.5310 | SNF1-related protein kinases, putative |
Trypanosoma brucei | Tb927.3.4560 | 5'-AMP-activated protein kinase catalytic subunit alpha, putative |
Trypanosoma congolense | TcIL3000_10_4460 | SNF1-related protein kinases, putative |
Trypanosoma cruzi | TcCLB.506679.80 | SNF1-related protein kinases, putative |
Trypanosoma cruzi | TcCLB.510329.210 | 5'-AMP-activated protein kinase catalytic subunit alpha, putative |
Toxoplasma gondii | TGME49_233905 | histone kinase SNF1, putative |
Theileria parva | TP04_0818 | 5'-AMP-activated protein kinase, putative |
Trichomonas vaginalis | TVAG_309990 | CAMK family protein kinase |
Trichomonas vaginalis | TVAG_324230 | CAMK family protein kinase |
Trichomonas vaginalis | TVAG_250560 | CAMK family protein kinase |
Trichomonas vaginalis | TVAG_094470 | CAMK family protein kinase |
Trichomonas vaginalis | TVAG_055350 | CAMK family protein kinase |
Trichomonas vaginalis | TVAG_232610 | CAMK family protein kinase |
Trichomonas vaginalis | TVAG_402790 | CAMK family protein kinase |
Trichomonas vaginalis | TVAG_350500 | CAMK family protein kinase |
Trichomonas vaginalis | TVAG_480240 | CAMK family protein kinase |
Trichomonas vaginalis | TVAG_367400 | CAMK family protein kinase |
Trichomonas vaginalis | TVAG_365840 | CAMK family protein kinase |
Trichomonas vaginalis | TVAG_320990 | CAMK family protein kinase |
Trichomonas vaginalis | TVAG_053820 | CAMK family protein kinase |
Trichomonas vaginalis | TVAG_456650 | CAMK family protein kinase |
Trichomonas vaginalis | TVAG_005980 | CAMK family protein kinase |
Trichomonas vaginalis | TVAG_065500 | CAMK family protein kinase |
Trichomonas vaginalis | TVAG_021680 | CAMK family protein kinase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.3.4560 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.3.4560 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.3.4560 | Trypanosoma brucei | significant gain of fitness in procyclic forms | alsford |
Tb927.3.4560 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb927.10.5310 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.5310 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.5310 this record | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.10.5310 this record | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
YKL101W | Saccharomyces cerevisiae | inviable | yeastgenome |
TGME49_233905 | Toxoplasma gondii | Probably essential | sidik |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | normal (PATO:0000461) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | decreased (PATO:0000468) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in procyclic forms . | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.9
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | protein kinase, AMP-activated, alpha 1 catalytic subunit | Compounds | References |
Homo sapiens | BR serine/threonine kinase 1 | Compounds | References |
Homo sapiens | protein kinase, AMP-activated, alpha 2 catalytic subunit | Compounds | References |
Rattus norvegicus | AMP-activated protein kinase, alpha-2 subunit | Compounds | References |
Homo sapiens | BR serine/threonine kinase 2 | Compounds | References |
Rattus norvegicus | AMP-activated protein kinase, alpha-1 subunit | Compounds | References |
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Rattus norvegicus | MAP kinase p38 alpha | 360 aa | 26.5% | 291 aa | Compounds | References |
Homo sapiens | Cyclin-dependent kinase 1/cyclin B1 | 297 aa | 30.7% | 290 aa | Compounds | References |
Rattus norvegicus | Jak1 protein | 210 aa | 26.1% | 203 aa | Compounds | References |
Oryctolagus cuniculus | Cyclin-dependent kinase 4 | 189 aa | 33.8% | 157 aa | Compounds | References |
Rattus norvegicus | Cell division protein kinase 5 | 292 aa | 28.9% | 291 aa | Compounds | References |
Schizosaccharomyces pombe 972h- | Casein kinase II subunit alpha | 332 aa | 21.5% | 307 aa | Compounds | References |
Rattus norvegicus | Serine/threonine-protein kinase pim-3 | 326 aa | 30.3% | 261 aa | Compounds | References |
Rattus norvegicus | Mitogen-activated protein kinase 1 | 358 aa | 27.5% | 338 aa | Compounds | References |
Plasmodium falciparum (isolate 3D7) | Cell division control protein 2 homolog | 288 aa | 31.6% | 294 aa | Compounds | References |
Sus scrofa | Casein kinase I isoform alpha | 125 aa | 26.8% | 112 aa | Compounds | References |
Patiria pectinifera | Cdc2 | 300 aa | 28.7% | 289 aa | Compounds | References |
1 literature reference was collected for this gene.